Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-06

Clinical Trial Update: Safety and Efficacy of Pramipexole Treatment in Resistant Obsessive-Compulsive Disorder (OCD) [Phase 2]

View source ↗

Summary

This document describes a Phase 2 clinical trial evaluating the safety and efficacy of pramipexole for treatment-resistant obsessive-compulsive disorder, which …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pramipexole (pramipexole)

Snippet

Sponsor: Clinical Academic Center (2CA-Braga) | Conditions: Obsessive-Compulsive Disorder | Phase 2 | Status: RECRUITING